BENIGN PROSTATIC HYPERPLASIA Products Affected
Step 1:
• alfuzosin ER 10 mg tablet,extended release 24 hr • doxazosin 1 mg tablet • doxazosin 2 mg tablet • doxazosin 4 mg tablet • doxazosin 8 mg tablet • tamsulosin 0.4 mg capsule • terazosin 1 mg capsule • terazosin 10 mg capsule • terazosin 2 mg capsule • terazosin 5 mg capsule
Step 2:
• Rapaflo 4 mg capsule • Rapaflo 8 mg capsule
Details Criteria
Coverage will be provided if terazosin, alfuzosin, doxazosin or tamsulosin has been tried (at least a 30 day supply in the prior 180 days).
BISPHOSPHONATES Products Affected
Step 1: • Step 2:
• Fosamax Plus D 70 mg-2,800 unit tablet • Fosamax Plus D 70 mg-5,600 unit tablet
Details Criteria
Coverage will be provided if alendronate, ibandronate, or risedronate has been tried (at least a 30 day supply in the prior 180 days).
GOUT Products Affected
• allopurinol 100 mg tablet • allopurinol 300 mg tablet
• Uloric 40 mg tablet • Uloric 80 mg tablet
Details Criteria
Coverage will be provided if allopurinol has been tried (at least a 30-day supply in the prior 180 days)
HMG-COA INHIBITORS Products Affected
• amlodipine 10 mg-atorvastatin 10 mg tablet • amlodipine 10 mg-atorvastatin 20 mg tablet • amlodipine 10 mg-atorvastatin 40 mg tablet • amlodipine 10 mg-atorvastatin 80 mg tablet • amlodipine 2.5 mg-atorvastatin 10 mg tablet • amlodipine 2.5 mg-atorvastatin 20 mg tablet • amlodipine 2.5 mg-atorvastatin 40 mg tablet • amlodipine 5 mg-atorvastatin 10 mg tablet • amlodipine 5 mg-atorvastatin 20 mg tablet • amlodipine 5 mg-atorvastatin 40 mg tablet • amlodipine 5 mg-atorvastatin 80 mg tablet • atorvastatin 10 mg tablet • atorvastatin 20 mg tablet • atorvastatin 40 mg tablet • atorvastatin 80 mg tablet • ezetimibe 10 mg-simvastatin 10 mg tablet 
